Talis Biomedical Corp Contracts & Agreements
52 Contracts & Agreements
- Business Finance (11 contracts)
- Business Operations (8)
- Human Resources (15)
- Real Estate (4)
- Uncategorized (14)
- Settlement Agreement dated August 30, 2024 entered into between Talis Biomedical Corporation and Kriya Therapeutics, Inc (Filed With SEC on September 6, 2024)
- Settlement Term Sheet dated August 29, 2024 entered into between Talis Biomedical Corporation, the Lead Plaintiff and the Class (Filed With SEC on September 3, 2024)
- Retention Agreement, dated August 19, 2024, by and between the Company and Rebecca Markovich, Interim Chief Financial Officer (Filed With SEC on August 19, 2024)
- Retention Agreement, dated August 19, 2024, by and between the Company and Robert Kelley, Chief Executive Officer (Filed With SEC on August 19, 2024)
- Retention Agreement, dated April 10, 2024, by and between the Company and Rebecca Markovich, Interim Chief Financial Officer (Filed With SEC on August 19, 2024)
- Indemnification Agreement dated August 1, 2024 by and between the Company and John T. Young, Jr (Filed With SEC on August 6, 2024)
- Indemnification Agreement dated August 1, 2024 by and between the Company and Patricia Ferrari (Filed With SEC on August 6, 2024)
- Director Services Agreement dated August 2, 2024 by and between the Company and John T. Young, Jr (Filed With SEC on August 6, 2024)
- Director Services Agreement dated August 2, 2024 by and between the Company and Patricia Ferrari (Filed With SEC on August 6, 2024)
- Waiver of Registration Rights entered into as of June 24, 2024 by and between the Registrant and Baker Brothers Life Sciences L.P. and 667, L.P (Filed With SEC on June 25, 2024)
- Waiver of Registration Rights entered into as of May 30, 2024 by and between the Registrant and Baker Brothers Life Sciences L.P. and 667, L.P (Filed With SEC on June 3, 2024)
- Retention Agreement, dated April 10, 2024, by and between the Company and Rebecca Markovich, Interim Chief Financial Officer (Filed With SEC on May 8, 2024)
- Waiver of Registration Rights entered into as of April 29, 2024 by and between the Registrant and Baker Brothers Life Sciences L.P. and 667, L.P (Filed With SEC on May 3, 2024)
- Waiver of Registration Rights entered into as of March 25, 2024 by and between the Registrant and Baker Brothers Life Sciences L.P. and 667, L.P (Filed With SEC on March 28, 2024)
- Retention Agreement, dated November 13, 2023, by and between the Company and Rebecca Markovich, Interim Chief Financial Officer (Filed With SEC on November 14, 2023)
- Offer Letter, dated July 27, 2023, by and between the Company and Andrew Lukowiak (Filed With SEC on August 2, 2023)
- Talis Biomedical Corporation Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 2, 2022)
- Talis Biomedical Corporation 2021 Employee Stock Purchase Plan, as amended (Filed With SEC on August 2, 2022)
- Talis Biomedical Corporation 2021 Equity Incentive Plan, as amended, and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on August 2, 2022)
- Amended Supply Agreement, dated December 15, 2021, by and between the Registrant and thinXXS Microtechnology (Filed With SEC on March 15, 2022)
- Talis Biomedical Corporation Severance and Change in Control Plan and Amended Form of Participation Agreement thereunder (Filed With SEC on March 15, 2022)
- Talis Biomedical Corporation Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 15, 2022)
- Offer Letter, dated December 8, 2021, by and between the Company and Robert Kelley (Filed With SEC on December 9, 2021)
- Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the Talis Biomedical Corporation 2021 Equity Incentive Plan (Filed With SEC on November 16, 2021)
- Separation and Consulting Agreement by and between the Registrant and Brian Coe, dated August 30, 2021 (Filed With SEC on November 16, 2021)
- Form of Restricted Stock Unit Award Grant Notice and Award Agreement (Restricted Stock Unit Award) under the Talis Biomedical Corporation 2021 Inducement Plan (Filed With SEC on November 15, 2021)
- Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the Talis Biomedical Corporation 2021 Inducement Plan (Filed With SEC on November 15, 2021)
- Talis Biomedical Corporation 2021 Inducement Plan (Filed With SEC on November 15, 2021)
- Offer Letter, dated November 1, 2021, by and between the Company and Brian Blaser (Filed With SEC on November 15, 2021)
- Lease Agreement, dated April 7, 2021, by and between the Registrant and SFF 3565 HAVEN, LLC (Filed With SEC on May 13, 2021)
- Registration Rights Agreement, dated March 26, 2021, by and among the Registrant, Baker Brothers Life Sciences L.P. and 667, L.P (Filed With SEC on March 30, 2021)
- Description of Securities (Filed With SEC on March 30, 2021)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on February 8, 2021)
- Form of Underwriting Agreement (Filed With SEC on February 8, 2021)
- Talis Biomedical Corporation 2021 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on February 8, 2021)
- Talis Biomedical Corporation 2021 Employee Stock Purchase Plan (Filed With SEC on February 8, 2021)
- Talis Biomedical Corporation Non-Employee Director Compensation Policy (Filed With SEC on February 8, 2021)
- Talis Biomedical Corporation Severance and Change in Control Plan (Filed With SEC on February 8, 2021)
- Lease, dated January 20, 2021, by and between the Registrant and Fulton Ogden Venture, LLC (Filed With SEC on February 8, 2021)
- Lease Agreement, dated January 20, 2021, by and between the Registrant and Westport Office Park, LLC (Filed With SEC on February 8, 2021)
- Amended and Restated Investor Rights Agreement, dated October 30, 2020, by and among the Registrant and certain of its stockholders (Filed With SEC on January 22, 2021)
- Contract, dated July 30, 2020, by and between the Registrant and the National Institutes of Health (Filed With SEC on January 22, 2021)
- Supply Agreement, dated May 22, 2020, by and between the Registrant and thinXXS Microtechnology AG (Filed With SEC on January 22, 2021)
- Business Park Lease, dated December 14, 2015, by and between the Registrant and Facebook, Inc., as amended on April 4, 2018 (Filed With SEC on January 22, 2021)
- Offer Letter, dated April 23, 2019, by and between the Registrant and Ramesh Ramakrishnan (Filed With SEC on January 22, 2021)
- Offer Letter, dated September 21, 2020, by and between the Registrant and Douglas Liu (Filed With SEC on January 22, 2021)
- Offer Letter, dated August 19, 2020, by and between the Registrant and Robert Kelley (Filed With SEC on January 22, 2021)
- Offer Letter, dated December 1, 2014, by and between the Registrant and Karen E. Flick (Filed With SEC on January 22, 2021)
- Offer Letter, dated April 3, 2020, by and between the Registrant and J. Roger Moody, Jr (Filed With SEC on January 22, 2021)
- Talis Biomedical Corporation 2013 Equity Incentive Plan and Forms of Option Grant Notice, Option Agreement and Notice of Exercise thereunder, as amended (Filed With SEC on January 22, 2021)
- Form of Indemnity Agreement, by and between the Registrant and its directors and officers (Filed With SEC on January 22, 2021)
- Nominating Agreement, dated November 1, 2019, by and among the Registrant, Baker Brothers Life Sciences, L.P. and 667, L.P (Filed With SEC on January 22, 2021)
